Haitao Zhu1, Xiaoyan Zhang1, Xiaoting Li1, Yanjie Shi1, Huici Zhu1, Yingshi Sun1. 1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Abstract
OBJECTIVE: To predict pathological nodal stage of locally advanced rectal cancer by a radiomic method that uses collective features of multiple lymph nodes (LNs) in magnetic resonance images before and after neoadjuvant chemoradiotherapy (NCRT). METHODS: A total of 215 patients were included in this study and chronologically divided into the discovery cohort (n=143) and validation cohort (n=72). In total, 2,931 pre-NCRT LNs and 1,520 post-NCRT LNs were delineated from all visible rectal LNs in magnetic resonance images. Geometric, first-order and texture features were extracted from each LN before and after NCRT. Collective features are defined as the maximum, minimum, mean, median value and standard deviation of each feature from all delineated LNs of each participant. LN-model is constructed from collective LN features by logistic regression model with L1 regularization to predict pathological nodal stage (ypN0 or ypN+). Tumor-model is constructed from tumor features for comparison by using DeLong test. RESULTS: The LN-model selects 7 features from 412 LN features, and the tumor-model selects 7 features from 82 tumor features. The area under the receiver operating characteristic curve (AUC) of LN-model in the discovery cohort is 0.818 [95% confidence interval (95% CI): 0.745-0.878], significantly (Z=2.09, P=0.037) larger than 0.685 (95% CI: 0.602-0.760) of the tumor-model. The AUC of LN-model in validation cohort is 0.812 (95% CI: 0.703-0.895), significantly (Z=3.106, P=0.002) larger than 0.517 (95% CI: 0.396-0.636) of the tumor-model. CONCLUSIONS: The usage of collective features from all visible rectal LNs performs better than the usage of tumor features for the prediction of pathological nodal stage of locally advanced rectal cancer.
OBJECTIVE: To predict pathological nodal stage of locally advanced rectal cancer by a radiomic method that uses collective features of multiple lymph nodes (LNs) in magnetic resonance images before and after neoadjuvant chemoradiotherapy (NCRT). METHODS: A total of 215 patients were included in this study and chronologically divided into the discovery cohort (n=143) and validation cohort (n=72). In total, 2,931 pre-NCRT LNs and 1,520 post-NCRT LNs were delineated from all visible rectal LNs in magnetic resonance images. Geometric, first-order and texture features were extracted from each LN before and after NCRT. Collective features are defined as the maximum, minimum, mean, median value and standard deviation of each feature from all delineated LNs of each participant. LN-model is constructed from collective LN features by logistic regression model with L1 regularization to predict pathological nodal stage (ypN0 or ypN+). Tumor-model is constructed from tumor features for comparison by using DeLong test. RESULTS: The LN-model selects 7 features from 412 LN features, and the tumor-model selects 7 features from 82 tumor features. The area under the receiver operating characteristic curve (AUC) of LN-model in the discovery cohort is 0.818 [95% confidence interval (95% CI): 0.745-0.878], significantly (Z=2.09, P=0.037) larger than 0.685 (95% CI: 0.602-0.760) of the tumor-model. The AUC of LN-model in validation cohort is 0.812 (95% CI: 0.703-0.895), significantly (Z=3.106, P=0.002) larger than 0.517 (95% CI: 0.396-0.636) of the tumor-model. CONCLUSIONS: The usage of collective features from all visible rectal LNs performs better than the usage of tumor features for the prediction of pathological nodal stage of locally advanced rectal cancer.
Authors: Ke Nie; Liming Shi; Qin Chen; Xi Hu; Salma K Jabbour; Ning Yue; Tianye Niu; Xiaonan Sun Journal: Clin Cancer Res Date: 2016-05-16 Impact factor: 12.531
Authors: Cornelis J H van de Velde; Petra G Boelens; Josep M Borras; Jan-Willem Coebergh; Andres Cervantes; Lennart Blomqvist; Regina G H Beets-Tan; Colette B M van den Broek; Gina Brown; Eric Van Cutsem; Eloy Espin; Karin Haustermans; Bengt Glimelius; Lene H Iversen; J Han van Krieken; Corrie A M Marijnen; Geoffrey Henning; Jola Gore-Booth; Elisa Meldolesi; Pawel Mroczkowski; Iris Nagtegaal; Peter Naredi; Hector Ortiz; Lars Påhlman; Philip Quirke; Claus Rödel; Arnaud Roth; Harm Rutten; Hans J Schmoll; Jason J Smith; Pieter J Tanis; Claire Taylor; Arne Wibe; Theo Wiggers; Maria A Gambacorta; Cynthia Aristei; Vincenzo Valentini Journal: Eur J Cancer Date: 2013-10-31 Impact factor: 9.162
Authors: Yanqi Huang; Lan He; Di Dong; Caiyun Yang; Cuishan Liang; Xin Chen; Zelan Ma; Xiaomei Huang; Su Yao; Changhong Liang; Jie Tian; Zaiyi Liu Journal: Chin J Cancer Res Date: 2018-02 Impact factor: 5.087
Authors: Sergei Bedrikovetski; Nagendra N Dudi-Venkata; Hidde M Kroon; Warren Seow; Ryash Vather; Gustavo Carneiro; James W Moore; Tarik Sammour Journal: BMC Cancer Date: 2021-09-26 Impact factor: 4.430